Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 159,588 251,929 319,053 656,089
Total Sell Value $13,270,852 $21,508,551 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 10 19 27 56
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 1303
  Page 52 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sager Erich Director   –       •      –    2006-02-22 4 AS $12.20 $12,200 D/D (1,000) 3,309     -
   Sager Erich Director   –       •      –    2006-02-22 4 OE $7.00 $7,000 D/D 1,000 4,309     -
   Bienaime Jean Jacques officerTitle   •       •      –    2006-02-01 4 AB $11.62 $17,500 D/D 1,500 14,000     -
   Sager Erich officerTitle   –       •      –    2006-01-27 4 AS $12.20 $30,500 D/D (2,500) 3,309     -
   Sager Erich officerTitle   –       •      –    2006-01-27 4 OE $7.00 $17,500 D/D 2,500 5,809     -
   Kakkis Emil D Chief Medical Officer   •       –      –    2006-01-04 4 OE $4.00 $200,000 D/D 50,000 88,144     -
   Bienaime Jean Jacques officerTitle   •       •      –    2006-01-03 4 B $10.76 $16,190 D/D 1,500 12,500 2.81     -
   Bienaime Jean Jacques officerTitle   •       •      –    2005-12-12 4 B $10.21 $10,208 D/D 1,000 11,000 2.81     -
   Sager Erich officerTitle   –       •      –    2005-12-05 4 AS $10.70 $80,261 D/D (7,500) 3,309     -
   Sager Erich officerTitle   –       •      –    2005-12-01 4/A S $10.42 $234,450 D/D (22,500) 3,309     -
   Bienaime Jean Jacques officerTitle   •       •      –    2005-12-01 4 AB $9.89 $14,916 D/D 1,500 10,000     -
   Sager Erich officerTitle   –       •      –    2005-12-01 4 S $10.42 $234,450 D/D (22,500) 0     -
   Starr Christopher M officerTitle   •       –      –    2005-12-01 4 AS $10.00 $105,710 D/D (10,571) 295,176     -
   Swiedler Stuart J SVP, Clinical Affairs   •       –      –    2005-11-21 4 AS $10.00 $300,000 D/D (30,000) 10,000     -
   Starr Christopher M SVP, Chief Scientific Officer   •       –      –    2005-11-21 4 AS $10.00 $105,710 D/D (10,571) 300,176     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2005-11-01 4 AB $8.36 $12,550 D/D 1,500 8,500     -
   Kakkis Emil D officerTitle   •       –      –    2005-10-31 4 A $3.43 $8,832 D/D 2,572 29,574     -
   Baffi Robert officerTitle   •       –      –    2005-10-31 4 A $3.43 $12,500 D/D 3,640 22,749     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2005-10-12 4/A AB $7.00 $3,500 D/D 500 7,000     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2005-10-12 4 AB $7.00 $3,500 D/D 500 6,500     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2005-10-06 4 AB $8.00 $4,000 D/D 500 6,500     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2005-10-03 4 AB $8.51 $12,765 D/D 1,500 6,000     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2005-09-01 4 AB $8.58 $38,588 D/D 4,500 4,500     -
   Klein Joseph III Director   –       •      –    2005-06-28 3 IO $0.00 $0 I/I 0 12,000     -
   Drapeau Louis Chief Executive Officer   •       –      –    2005-05-02 4 A $3.43 $13,750 D/D 4,004 14,934     -
  1303 Records found
  Previous  50  51  52  53   
  Page 52 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us